Location History:
- Bad Krozingen, DE (2013)
- München, DE (2014)
Company Filing History:
Years Active: 2013-2014
Title: Innovations by Peter Kraahs in Pharmaceutical Composition
Introduction
Peter Kraahs is an accomplished inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that enhance the ease of swallowing for patients, especially young children. With a total of 2 patents, his work focuses on improving patient compliance and comfort.
Latest Patents
Kraahs' latest patents include a "Particulate form of a pharmaceutical composition which is easy to swallow." This invention relates to a pharmaceutical composition designed for direct oral administration, which is particularly beneficial for young children. The composition consists of one or more particles that contain a core with the active ingredient, coated to enhance swallowability. The particles are ideally administered with a powder or granules that generate additional saliva, making the swallowing process smoother and more pleasant.
Another notable patent is the "Melt-coated pharmaceutical composition with fast release." This invention outlines a process for producing a solid, coated pharmaceutical composition through a melt coating process. The resulting composition is designed to have a fast release, improving the efficacy of the pharmaceutical product.
Career Highlights
Peter Kraahs is currently associated with Losan Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to enhancing the usability of medications, ensuring that they are accessible and easy to consume for all patients.
Collaborations
Kraahs collaborates with talented professionals in his field, including Peter Gruber and Stefanie Bold. These partnerships contribute to the development of innovative solutions in pharmaceutical compositions.
Conclusion
Peter Kraahs is a notable inventor whose work in pharmaceutical compositions has the potential to significantly improve patient experiences. His innovative patents reflect a dedication to enhancing medication usability, particularly for young children.